ALIGN TECHNOLOGY, INC.
|
(Exact
Name of Registrant as Specified in Its
Charter)
|
(State
or Other Jurisdiction of
Incorporation)
|
0-32259
|
94-3267295
|
|
(Commission
File Number)
|
(IRS
Employer Identification
No.)
|
881 Martin Avenue, Santa Clara,
California
|
95050
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
(408) 470-1000
|
(Registrant’s
Telephone Number, Including Area
Code)
|
(Former
Name or Former Address, if Changed Since Last
Report)
|
Exhibit
No.
|
Description
|
99.1
|
Press
Release of Align Technology, Inc. dated January 28,
2009
|
ALIGN
TECHNOLOGY, INC.
|
||
By:
|
/s/Kenneth
B. Arola
|
|
Kenneth
B. Arola
|
||
Vice
President, Finance and Chief Financial
Officer
|
Exhibit
No.
|
Description
|
99.1
|
Press
Release of Align Technology, Inc. dated January 28,
2009
|
|
Press
Contact
|
|
Shirley
Stacy
|
Shannon
Mangum Henderson
|
Align
Technology, Inc.
|
Ethos
Communication, Inc.
|
(678)
540-9222
|
|
sstacy@aligntech.com
|
align@ethoscommunication.com
|
Key
GAAP Operating Results
|
Q4
08
|
Q3
08
|
Q4
07
|
|||||||||
Gross
Margin
|
72.7 | % | 75.0 | % | 73.6 | % | ||||||
Operating
Expense
|
$ | 52.6M | $ | 50.7M | $ | 48.4M | ||||||
Operating
Margin
|
1.8 | % | 7.6 | % | 6.9 | % | ||||||
Net
Profit
|
$ | 65.5M | $ | 5.2M | $ | 5.7M | ||||||
Earnings
Per Diluted Share (EPS)
|
$ | 0.98 | $ | 0.08 | $ | 0.08 | ||||||
Key
Non-GAAP Operating Results
|
Q4
08
|
Q3
08
|
Q4
07
|
|||||||||
Non-GAAP
Operating Expense
|
$ | 48.5M | $ | 48.5M | $ | 48.4M | ||||||
Non-GAAP
Profit from Operations
|
$ | 5.4M | $ | 7.9M | $ | 5.0M | ||||||
Non-GAAP
Net Profit
|
$ | 4.9M | $ | 7.3M | $ | 5.7M | ||||||
Non-GAAP
Earnings Per Diluted Share (EPS)
|
$ | 0.07 | $ | 0.11 | $ | 0.08 |
Revenue
by Channel:
|
Q4
08
|
Q4
08/Q3 08
%
Change
|
Q4
08/Q4 07
%
Change
|
|||||||||
U.S.
Orthodontists
|
$ | 21.2 | (5.0 | )% | (1.2 | )% | ||||||
U.S.
GP Dentists
|
$ | 33.6 | (4.5 | )% | 0.3 | % | ||||||
International
|
$ | 16.2 | 7.4 | % | 14.4 | % | ||||||
Training
and Other
|
$ | 3.1 | 20.4 | % | (8.6 | )% | ||||||
Total
Revenue
|
$ | 74.1 | (1.4 | )% | 2.2 | % | ||||||
Average
Selling Price (ASP):
|
Q4
08
|
Q4
08/Q3 08
%
Change
|
Q4
08/Q4 07
%
Change
|
|||||||||
Total
Worldwide Blended ASP
|
$ | 1,370 | (0.7 | )% | 0.7 | % | ||||||
Total
Worldwide ASP excluding Invisalign Express
|
$ | 1,470 | (2.0 | )% | 0.0 | % | ||||||
U.S.
Orthodontists Blended ASP
|
$ | 1,300 | 0.8 | % | 4.8 | % | ||||||
U.S.
GP Dentists Blended ASP
|
$ | 1,350 | (0.7 | )% | 2.3 | % | ||||||
International
|
$ | 1,510 | (9.0 | )% | (14.2 | )% | ||||||
Number
of Cases Shipped:
|
Q4
08
|
Q4
08/Q3 08
%
Change
|
Q4
08/Q4 07
%
Change
|
|||||||||
U.S.
Orthodontists – Full Invisalign
|
14,010 | (6.6 | )% | (1.8 | )% | |||||||
U.S.
Orthodontists – Invisalign Express
|
3,000 | 1.0 | % | (2.0 | )% | |||||||
U.S.
GP Dentists – Full Invisalign
|
20,460 | (2.9 | )% | (1.6 | )% | |||||||
U.S.
GP Dentists – Invisalign Express
|
4,400 | (4.8 | )% | (5.0 | )% | |||||||
International–
Full Invisalign
|
10,480 | 17.1 | % | 31.8 | % | |||||||
International–
Invisalign Express
|
290 | 52.6 | % | 141.7 | % | |||||||
Total
Cases Shipped
|
52,640 | (0.3 | )% | 3.6 | % | |||||||
Number
of Doctors Cases were Shipped to:
|
Q4
08
|
|||||||||||
U.S.
Orthodontists
|
3,670 | |||||||||||
U.S.
GP Dentists
|
10,760 | |||||||||||
International
|
3,160 | |||||||||||
Total
Doctors Cases were Shipped to Worldwide
|
17,590 | |||||||||||
Number
of Doctors Trained Worldwide:
|
Q4
08
|
Cumulative
|
||||||||||
U.S.
Orthodontists
|
60 | 8,670 | ||||||||||
U.S.
GP Dentists
|
1,360 | 32,660 | ||||||||||
International
|
520 | 14,180 | ||||||||||
Total
Doctors Trained Worldwide
|
1,940 | 55,510 | ||||||||||
Multiple
Case Doctors (Cumulative as of):
|
Q4
08
|
|||||||||||
U.S.
Orthodontists
|
90.7 | % | ||||||||||
U.S.
GP Dentists
|
86.0 | % | ||||||||||
International
|
77.4 | % | ||||||||||
Doctors
Starting Invisalign Treatment (Cumulative as of):
|
Q4
08
|
|||||||||||
U.S.
Orthodontists
|
7,140 | |||||||||||
U.S.
GP Dentists
|
25,960 | |||||||||||
International
|
8,160 | |||||||||||
Total
Doctors Starting Invisalign Treatment
|
41,260 |
Doctor
Utilization Rates*:
|
Q4
08
|
Q3
08
|
Q4
07
|
|||||||||
U.S.
Orthodontists
|
4.6 | 4.8 | 4.8 | |||||||||
U.S.
GP Dentists
|
2.3 | 2.4 | 2.5 | |||||||||
International
|
3.4 | 3.2 | 3.2 | |||||||||
Total
Utilization Rate
|
3.0 | 3.0 | 3.1 |
Three Months Ended
|
Year Ended
|
|||||||||||||||
|
December 31,
2008
|
December 31,
2007
|
December 31,
2008
|
December 31,
2007
|
||||||||||||
Net
revenues
|
$ | 74,125 | $ | 72,517 | 303,976 | $ | 284,332 | |||||||||
Cost
of revenues
|
20,233 | 19,127 | 78,850 | 75,035 | ||||||||||||
Gross
profit
|
53,892 | 53,390 | 225,126 | 209,297 | ||||||||||||
Operating
expenses:
|
||||||||||||||||
Sales
and marketing
|
26,325 | 26,502 | 115,062 | 98,231 | ||||||||||||
General
and administrative
|
16,249 | 15,266 | 62,154 | 53,280 | ||||||||||||
Research
and development
|
5,951 | 6,610 | 26,165 | 25,727 | ||||||||||||
Restructuring
|
4,042 | 6,231 | - | |||||||||||||
Patients
First Program
|
- | - | - | (1,796 | ) | |||||||||||
Total
operating expenses
|
52,567 | 48,378 | 209,612 | 175,442 | ||||||||||||
Profit
from operations
|
1,325 | 5,012 | 15,514 | 33,855 | ||||||||||||
Interest
and other income (expense), net
|
(111 | ) | 852 | 1,562 | 3,095 | |||||||||||
Profit
before income taxes
|
1,214 | 5,864 | 17,076 | 36,950 | ||||||||||||
Provision
for (benefit from) income taxes
|
(64,282 | ) | 196 | (62,911 | ) | 1,226 | ||||||||||
Net
profit
|
$ | 65,496 | $ | 5,668 | $ | 79,987 | $ | 35,724 | ||||||||
Net
profit per share
|
||||||||||||||||
-
basic
|
$ | 0.99 | $ | 0.08 | $ | 1.20 | $ | 0.53 | ||||||||
-
diluted
|
$ | 0.98 | $ | 0.08 | $ | 1.18 | $ | 0.50 | ||||||||
Shares
used in computing net profit per share
|
||||||||||||||||
-
basic
|
66,440 | 68,562 | 66,812 | 67,176 | ||||||||||||
-
diluted
|
66,816 | 71,864 | 68,064 | 71,444 |
December 31, 2008
|
December 31, 2007
|
|||||||
ASSETS
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 87,100 | $ | 89,119 | ||||
Restricted
cash
|
- | 21 | ||||||
Marketable
securities, short-term
|
23,066 | 38,771 | ||||||
Accounts
receivable, net
|
52,362 | 44,850 | ||||||
Inventories,
net
|
1,965 | 2,910 | ||||||
Other
current assets
|
13,414 | 8,846 | ||||||
Total
current assets
|
177,907 | 184,517 | ||||||
Property
and equipment, net
|
26,979 | 25,320 | ||||||
Goodwill
and intangible assets, net
|
8,266 | 11,093 | ||||||
Other
long-term assets
|
66,189 | 1,831 | ||||||
Total
assets
|
$ | 279,341 | $ | 222,761 | ||||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable
|
$ | 5,580 | $ | 9,222 | ||||
Accrued
liabilities
|
38,282 | 39,875 | ||||||
Deferred
revenue
|
16,710 | 12,362 | ||||||
Total
current liabilities
|
60,572 | 61,459 | ||||||
Other
long term liabilities
|
229 | 148 | ||||||
Total
liabilities
|
60,801 | 61,607 | ||||||
Total
stockholders' equity
|
218,540 | 161,154 | ||||||
Total
liabilities and stockholders' equity
|
$ | 279,341 | $ | 222,761 |
Three Months
Ended
|
||||||||||||
December 31,
2008
|
September 30,
2008
|
December 31,
2007
|
||||||||||
GAAP
Operating expenses
|
$ | 52,567 | $ | 50,716 | $ | 48,378 | ||||||
Restructuring
|
(4,042 | ) | (2,189 | ) | - | |||||||
Non-GAAP
Operating expenses
|
$ | 48,525 | $ | 48,527 | $ | 48,378 |
Three Months
Ended
|
||||||||||||
December 31,
2008
|
September 30,
2008
|
December 31,
2007
|
||||||||||
GAAP
Profit from Operations
|
$ | 1,325 | $ | 5,691 | $ | 5,012 | ||||||
Restructuring
|
4,042 | 2,189 | - | |||||||||
Non-GAAP
Profit from Operations
|
$ | 5,367 | $ | 7,880 | $ | 5,012 |
Three Months
Ended
|
||||||||||||
December 31,
2008
|
September 30,
2008
|
December 31,
2007
|
||||||||||
GAAP
Net profit
|
$ | 65,496 | $ | 5,157 | $ | 5,668 | ||||||
Restructuring
|
4,042 | 2,189 | - | |||||||||
Tax
effect on non-GAAP adjustments
|
(43 | ) | (86 | ) | - | |||||||
Release
of tax valuation allowance
|
(64,608 | ) | - | - | ||||||||
Non-GAAP
Net profit
|
$ | 4,887 | $ | 7,260 | $ | 5,668 | ||||||
Diluted
Net profit per share:
|
||||||||||||
GAAP
|
$ | 0.98 | $ | 0.08 | $ | 0.08 | ||||||
Non-GAAP
|
$ | 0.07 | $ | 0.11 | $ | 0.08 | ||||||
Shares
used in computing diluted net profit per share
|
66,816 | 68,704 | 71,864 |
Year Ended
|
||||||||
December 31,
2008
|
December 31,
2007
|
|||||||
GAAP
Operating expenses
|
$ | 209,612 | $ | 175,442 | ||||
Patients
First Program
|
- | 1,796 | ||||||
Restructuring
|
(6,231 | ) | - | |||||
Non-GAAP
Operating expenses
|
$ | 203,381 | $ | 177,238 |
Year Ended
|
||||||||
December 31,
2008
|
December 31,
2007
|
|||||||
GAAP
Profit from Operations
|
$ | 15,514 | $ | 33,855 | ||||
Patients
First Program
|
- | (1,796 | ) | |||||
Restructuring
|
6,231 | - | ||||||
Non-GAAP
Profit from Operations
|
$ | 21,745 | $ | 32,059 |
Year Ended
|
||||||||
December 31,
2008
|
December 31,
2007
|
|||||||
GAAP
Net profit
|
$ | 79,987 | $ | 35,724 | ||||
Patients
First Program
|
- | (1,796 | ) | |||||
Restructuring
|
6,231 | - | ||||||
Tax
effect of non-GAAP adjustments
|
(129 | ) | 43 | |||||
Release
of tax valuation allowance
|
(64,608 | ) | - | |||||
Non-GAAP
Net profit
|
$ | 21,481 | $ | 33,971 | ||||
Diluted
Net profit per share:
|
||||||||
GAAP
|
$ | 1.18 | $ | 0.50 | ||||
Non-GAAP
|
$ | 0.32 | $ | 0.48 | ||||
Shares
used in computing diluted net profit per share
|
68,064 | 71,444 |
Q1
2009
|
||||||
GAAP
|
Adjustment
|
(a)
|
Non-GAAP
|
|||
Net
Revenue
|
$65.0
- $69.0
|
$65.0
- $69.0
|
||||
Gross
Margin
|
72.0%
- 72.5%
|
72.0%
- 72.5%
|
||||
Operating
Expenses
|
$49.5
- $50.5
|
$1.0
|
(a)
|
$48.5
- $49.5
|
||
Operating
Margin
|
(4)%
- 0%
|
1%
- 2%
|
(2)%
- 1%
|
|||
Net
Income per Diluted Share
|
$(0.04)
- $0.00
|
$0.01
|
$(0.03)
- $0.01
|
|||
Stock
Based Compensation Expense:
|
||||||
Cost
of Revenues
|
$0.4
|
$0.4
|
||||
Operating
Expenses
|
$3.8
|
$3.8
|
||||
Total
Stock Based Compensation Expense
|
$4.2
|
$4.2
|
||||
(a) Restructuring
charges
|
||||||
Business
Metrics:
|
||||||
Q1
2009
|
||||||
Case
Shipments
|
44.5K
- 47.0K
|
|||||
Cash
|
$108M
- $113M
|
|||||
DSO
|
~65
days
|
|||||
Capex
|
$3.0M
- $5.0M
|
|||||
Depreciation
& Amortization
|
$2.0M
- $3.0M
|
|||||
Diluted
Shares Outstanding
|
69M
|
|||||
Full
Year 2009:
|
FY
2009
|
|||||
Stock
Based compensation
|
$20M
|
|||||
Diluted
Shares Outstanding
|
70M
|